BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Human chorionic gonadotropin
,
Lipopolysaccharide
,
rs7903146
,
BRCA1
,
Leukemia
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
zap70 protein human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
CD4 T-cells with MTOR, ZAP70 silencing, or treated with Rapamycin or Cyclosporin A
Chronic lymphocytic leukemia B cells marked with IgVH mutation (mutIgVH) and ZAP70 expression
B cells from chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA
Explore Curated Studies Results
Literature
Most Relevant Literature
Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lympho…
A boy with a novel homozygous ZAP70 mutation presenting with a dermatological phenotype and postnata…
γδ CD8+ T cells and novel genetic variants in ZAP70 deficiency.
Novel Compound Heterozygous ZAP70 R37G A507T Mutations in Infant with Severe Immunodeficiency.
Zeta-associated protein 70 expression in chronic lymphocytic leukemia: Relevance in Indian context.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Es…
Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ